BIOMAT Database Logo BIOMAT Database Logo

[Inhibition of lactation with 2-bromo-alpha-ergocryptine (CB-154)]. 1978

E Solla, and S Murru, and A M Onano, and G B Melis

UI MeSH Term Description Entries
D007774 Lactation The processes of milk secretion by the maternal MAMMARY GLANDS after PARTURITION. The proliferation of the mammary glandular tissue, milk synthesis, and milk expulsion or let down are regulated by the interactions of several hormones including ESTRADIOL; PROGESTERONE; PROLACTIN; and OXYTOCIN. Lactation, Prolonged,Milk Secretion,Lactations, Prolonged,Milk Secretions,Prolonged Lactation,Prolonged Lactations
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D001971 Bromocriptine A semisynthetic ergotamine alkaloid that is a dopamine D2 agonist. It suppresses prolactin secretion. 2-Bromoergocryptine,Bromocryptin,2-Bromo-alpha-ergocryptine,2-Bromo-alpha-ergokryptine,2-Bromoergocryptine Mesylate,2-Bromoergocryptine Methanesulfonate,2-Bromoergokryptine,Bromocriptin,Bromocriptine Mesylate,CB-154,Parlodel,2 Bromo alpha ergocryptine,2 Bromo alpha ergokryptine,2 Bromoergocryptine,2 Bromoergocryptine Mesylate,2 Bromoergocryptine Methanesulfonate,2 Bromoergokryptine,CB 154,CB154,Mesylate, 2-Bromoergocryptine,Mesylate, Bromocriptine,Methanesulfonate, 2-Bromoergocryptine
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

E Solla, and S Murru, and A M Onano, and G B Melis
Prevention and suppression of post-partum lactation with 2-bromo-alpha-ergocryptine (CB-154).
January 1977, Clinical endocrinology,
E Solla, and S Murru, and A M Onano, and G B Melis
[Inhibition of postpartal lactation with 2-bromo-alpha-ergocryptine].
January 1978, Wiener medizinische Wochenschrift (1946),
E Solla, and S Murru, and A M Onano, and G B Melis
Treatment of benign fibrocystic disease of the breast with 2-bromo-alpha-ergocryptine (CB 154).
October 1982, International journal of clinical pharmacology, therapy, and toxicology,
E Solla, and S Murru, and A M Onano, and G B Melis
[CB-154 (2-brom-alpha-ergocryptine) loading test].
June 1979, Nihon rinsho. Japanese journal of clinical medicine,
E Solla, and S Murru, and A M Onano, and G B Melis
Effect of 2-bromo-alpha-ergocryptine (CB-154) on estrogen induced growth of the rat prostate.
March 1978, Investigative urology,
E Solla, and S Murru, and A M Onano, and G B Melis
[Two cases of amenorrhea-galactorrhea with sterility treated with CB 154 (2 bromo-alpha-ergocryptine): ovulation and pregnancy].
January 1975, Gynecologie,
E Solla, and S Murru, and A M Onano, and G B Melis
Metabolic effects of 2-bromo ergocryptine-methane-sulphonate (CB 154) in the rat.
March 1975, The Journal of endocrinology,
E Solla, and S Murru, and A M Onano, and G B Melis
The inhibition of prolactin secretion in man by CB-154 (2-Br-alpha-ergocryptine).
November 1972, The Journal of clinical endocrinology and metabolism,
E Solla, and S Murru, and A M Onano, and G B Melis
Pregnancy following 2-bromo-alpha-ergocryptine (CB-154)-induced ovulation in an acromegalic patient with galactorrhea and amenorrhea.
March 1976, Fertility and sterility,
E Solla, and S Murru, and A M Onano, and G B Melis
Metaclopramide and prolactin secretion in man: effects of pretreatment with L-dopa and 2-bromo-alpha-ergocryptine (CB-154).
June 1975, IRCS journal of medical science,
Copied contents to your clipboard!